Filtered By:
Condition: Bleeding

This page shows you your search results in order of date. This is page number 7.

Order by Relevance | Date

Total 12509 results found since Jan 2013.

Fixed dose combination therapies in primary cardiovascular disease prevention in different groups: an individual participant meta-analysis
Conclusions In participants with intermediate cardiovascular risk, FDCs produce larger cardiovascular benefits in older individuals, which appear greater with aspirin. Trial registration number HOPE-3, NCT00468923; TIPS-3, NCT016464137; PolyIran, NCT01271985.
Source: Heart - August 24, 2023 Category: Cardiology Authors: Dagenais, G. R., Pais, P., Gao, P., Roshandel, G., Malekzadeh, R., Joseph, P., Yusuf, S. Tags: Cardiac risk factors and prevention Source Type: research

Incidence of Arterial Thrombotic and Bleeding Events in Patients Who Develop Cancer After ST-elevation Myocardial Infarction
Conclusion Cancers increase unpredictable bleeding but not arterial thrombotic events in patients after STEMI.PMID:37612081 | DOI:10.2169/internalmedicine.2385-23
Source: Internal Medicine - August 23, 2023 Category: Internal Medicine Authors: Toshiharu Fujii Yuji Ikari Source Type: research

Minimally invasive, surgical, and transcatheter aortic valve replacement: Network meta-analysis
CONCLUSIONS: MS was protective against 30-day mortality, stroke, AKI, and long-term mortality compared to FS; TAVR showed higher rates of 30-day PVL and PPM but was protective against AKI. Conversely, MT showed higher rates of 30-day PVL and major bleeding. With the emergence of TAVR, the appropriate benchmarks for SAVR comparison in future trials should be the minimally-invasive SAVR approaches to provide clinical equipoise.PMID:37611742 | DOI:10.1016/j.jjcc.2023.08.010
Source: Journal of Cardiology - August 23, 2023 Category: Cardiology Authors: Ahmed K Awad Adham Ahmed Dave M Mathew Kathryn S Varghese Serena M Mathew Sofia Khaja Paige C Newell Alexis K Okoh Sameer Hirji Source Type: research

Incidence of Arterial Thrombotic and Bleeding Events in Patients Who Develop Cancer After ST-elevation Myocardial Infarction
Conclusion Cancers increase unpredictable bleeding but not arterial thrombotic events in patients after STEMI.PMID:37612081 | DOI:10.2169/internalmedicine.2385-23
Source: Internal Medicine - August 23, 2023 Category: Internal Medicine Authors: Toshiharu Fujii Yuji Ikari Source Type: research

Minimally invasive, surgical, and transcatheter aortic valve replacement: Network meta-analysis
CONCLUSIONS: MS was protective against 30-day mortality, stroke, AKI, and long-term mortality compared to FS; TAVR showed higher rates of 30-day PVL and PPM but was protective against AKI. Conversely, MT showed higher rates of 30-day PVL and major bleeding. With the emergence of TAVR, the appropriate benchmarks for SAVR comparison in future trials should be the minimally-invasive SAVR approaches to provide clinical equipoise.PMID:37611742 | DOI:10.1016/j.jjcc.2023.08.010
Source: Journal of Cardiology - August 23, 2023 Category: Cardiology Authors: Ahmed K Awad Adham Ahmed Dave M Mathew Kathryn S Varghese Serena M Mathew Sofia Khaja Paige C Newell Alexis K Okoh Sameer Hirji Source Type: research

Incidence of Arterial Thrombotic and Bleeding Events in Patients Who Develop Cancer After ST-elevation Myocardial Infarction
Conclusion Cancers increase unpredictable bleeding but not arterial thrombotic events in patients after STEMI.PMID:37612081 | DOI:10.2169/internalmedicine.2385-23
Source: Internal Medicine - August 23, 2023 Category: Internal Medicine Authors: Toshiharu Fujii Yuji Ikari Source Type: research

Minimally invasive, surgical, and transcatheter aortic valve replacement: Network meta-analysis
CONCLUSIONS: MS was protective against 30-day mortality, stroke, AKI, and long-term mortality compared to FS; TAVR showed higher rates of 30-day PVL and PPM but was protective against AKI. Conversely, MT showed higher rates of 30-day PVL and major bleeding. With the emergence of TAVR, the appropriate benchmarks for SAVR comparison in future trials should be the minimally-invasive SAVR approaches to provide clinical equipoise.PMID:37611742 | DOI:10.1016/j.jjcc.2023.08.010
Source: Journal of Cardiology - August 23, 2023 Category: Cardiology Authors: Ahmed K Awad Adham Ahmed Dave M Mathew Kathryn S Varghese Serena M Mathew Sofia Khaja Paige C Newell Alexis K Okoh Sameer Hirji Source Type: research